位置:成果数据库 > 期刊 > 期刊详情页
中药单药提取物抗肺癌的研究进展
  • ISSN号:1000-1719
  • 期刊名称:《辽宁中医杂志》
  • 时间:0
  • 分类:R284.2[医药卫生—中药学;医药卫生—中医学]
  • 作者机构:[1]中国中医科学院广安门医院肿瘤科,北京100053
  • 相关基金:国家自然科学基金资助项目(81072970)
中文摘要:

肺癌是常见的肺部原发恶性肿瘤,其发病率在近数十年来一直呈上升趋势,是肿瘤工作者亟待解决的重大课题之一。随着靶向药物的问世,易瑞沙等初步显示了较好的临床疗效,但其副作用及如何进一步提高抑瘤率及生存期、生活质量等问题,仍需加强研究。中医药抗肺癌研究近年来亦进步较快,许多中药单药均显示出对肺癌一定的抑制作用,但在药物机制研究方面仍存在着不少问题。现将近年来中药单药提取物抗肺癌的研究进展作一简要综述,以期对进一步临床与实验研究提供帮助。

英文摘要:

Lung cancer is a kind of common malignant tumor, frequently occurring in bronchial epithelium. In recent decades, its incidence has been on an upward trend, and it becomes one of major task for medical workers and researchers to resolve. With the advent of target drugs, they initially show a good clinical efficacy. But their side effects are very difficult to avoid. And how to improve tumor inhibition rate and quality of life ,and prolong survival period of those patients who accepted Iressa's treatment, are still problems for tumor researchers to resolve. In recent years, many studies of Chinese medicine in treating lung cancer have also made great progress, and a lot of Chinese traditional medicine has showed their inhibitory, effects on lung cancer. But the researches in drug mechanism still have many problems. This article will make a brief review of those researches and would raise some questions for next clinical and experimental research.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《辽宁中医杂志》
  • 北大核心期刊(2014版)
  • 主管单位:辽宁省卫生和计划生育委员会
  • 主办单位:辽辽宁中医药大学
  • 主编:张立德
  • 地址:沈阳市皇姑区崇山东路79号
  • 邮编:110032
  • 邮箱:lnzy@vip.163.com
  • 电话:024-31207233
  • 国际标准刊号:ISSN:1000-1719
  • 国内统一刊号:ISSN:21-1128/R
  • 邮发代号:8-87
  • 获奖情况:
  • 中国自然科学核心期刊,中国生物医学核心期刊,中国中医药优秀期刊,中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2014版)
  • 被引量:51754